The burden of immune thrombocytopenia in adults: evaluation of the thrombopoietin receptor agonist romiplostim.
about
Impact of self-administration of romiplostim by patients with chronic immune thrombocytopenia compared with administration by a healthcare provider.Emerging drugs for immune thrombocytopenia (ITP).Patterns of care and burden of chronic idiopathic thrombocytopenic purpura in Brazil.Splenectomy in ITP: we keep removing a healthy functional organ.
P2860
The burden of immune thrombocytopenia in adults: evaluation of the thrombopoietin receptor agonist romiplostim.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The burden of immune thrombocy ...... receptor agonist romiplostim.
@ast
The burden of immune thrombocy ...... receptor agonist romiplostim.
@en
type
label
The burden of immune thrombocy ...... receptor agonist romiplostim.
@ast
The burden of immune thrombocy ...... receptor agonist romiplostim.
@en
prefLabel
The burden of immune thrombocy ...... receptor agonist romiplostim.
@ast
The burden of immune thrombocy ...... receptor agonist romiplostim.
@en
P2093
P1476
The burden of immune thrombocy ...... receptor agonist romiplostim.
@en
P2093
Jon Fryzek
Marieke Schoonen
Robert Deuson
Susan D Mathias
P304
P356
10.3111/13696998.2012.688902
P407
P577
2012-05-23T00:00:00Z